(Q41650806)

English

Differences in TIMI frame count following successful reperfusion with stenting or percutaneous transluminal coronary angioplasty for acute myocardial infarction

scientific article published on May 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Differences in TIMI frame count following successful reperfusion with stenting or percutaneous transluminal coronary angioplasty for acute myocardial infarction (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

author name string

Edep ME

1

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Guarneri EM

2

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Teirstein PS

3

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Phillips PS

4

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Brown DL

5

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

83

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

1326-1329

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900094-6

7 January 2021

A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900094-6

7 January 2021

Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Thrombolysis--the preferred treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900094-6

7 January 2021

Stent implantation in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900094-6

7 January 2021

Coronary stenting in patients undergoing percutaneous transluminal coronary angioplasty during acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900094-6

7 January 2021

Primary stent implantation without coumadin in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900094-6

7 January 2021

Direct angioplasty and stenting of the infarct-related artery in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900094-6

7 January 2021

Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900094-6

7 January 2021

Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900094-6

7 January 2021

TIMI frame count: a quantitative method of assessing coronary artery flow

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900094-6

7 January 2021

Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900094-6

7 January 2021

TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900094-6

7 January 2021

Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900094-6

7 January 2021

Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900094-6

7 January 2021

Identifiers

10.1016/S0002-9149(99)00094-6

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41650806&oldid=1925512007"